U.S. Markets open in 59 mins

China Pharma Holdings, Inc. (CPHI)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.7158+0.0308 (+4.50%)
At close: 3:59PM EDT

0.7158 0.00 (0.00%)
Pre-Market: 8:00AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.6850
Open0.6850
Bid0.6950 x 900
Ask0.7700 x 1000
Day's Range0.6851 - 0.7400
52 Week Range0.3200 - 1.6300
Volume461,926
Avg. Volume3,248,471
Market Cap32.626M
Beta (5Y Monthly)0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.0660
Earnings DateNov 13, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
  • China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
    PR Newswire

    China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, commented on the policy statements in "Several Special Measures to Support the Construction of Hainan Free Trade Port to Relax Market Access" released by the National Development and Reform Commission and the Ministry of Commerce in April. This statement follows the release of the Overall Plan for the Construction of Hainan Free Trade Port in June 2020 and the establishment of the Hainan Boao Lecheng International Medical Tourism Pilot District in 2013, which were both approved by the State Council.

  • China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
    PR Newswire

    China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscal year ended December 31, 2020.

  • China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
    PR Newswire

    China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.